在设计的G-四重体向酸中,减弱了VEGF-A的表达,防止了癌细胞中的血管生成
Nilanjan Banerjee1, Laboni Roy2, Suman Panda2
1Non-Coding Genome Group, Department of Structural Biology, CEITEC-Central European Institute of Technology, Brno, Czech Republic.
Chemical biology & drug design
|December 20, 2024
概括
这项研究引入了一种新,可以稳定VEGF-A G-四重复结构,有效减少基因表达和阻断癌症血管生成. 这种为癌症治疗提供了一个有前途的治疗策略.
科学领域:
- 分子生物学分子生物学
- 生物化学 生化学
- 癌症研究 癌症研究
背景情况:
- 血管内皮生长因子-A (VEGF-A) 驱动血管新生,对癌症生长至关重要.
- 维格基因促进体含有G-四重复 (G4) 结构,调节其活性.
- 癌症的进展使VEGF-A G4不稳定,增加VEGF-A转录和促进血管生成.
研究的目的:
- 设计和描述一种可以结合和稳定VEGF-A G4结构的.
- 调查对VEGF-A基因表达和下游信号传递的影响.
- 为了评估的潜力抑制癌细胞中的血管生成.
主要方法:
- 高分辨率核磁共振 (NMR) 谱学用于研究G4相互作用.
- 模拟分子动力学以阐明结合机制.
- 定量聚合酶连锁反应 (qPCR) 和西式涂抹分析基因和蛋白质表达.
- 在癌症模型中评估抗血管原效应.
主要成果:
- 一个设计的成功地结合并稳定了VEGF-A G4结构.
- 由诱导的G4稳定显著降低了VEGF-A基因表达.
- 治疗改变了VEGF-A信号级联,并抑制了血管生成.
- 核磁共振和模拟提供了对G4相互作用的详细见解.
结论:
- 可以有效地设计以准和稳定像VEGF-A G4.4这样的G-四重复结构.
- 这种方法提供了一种抑制VEGF-A表达和阻断癌症血管生成的新策略.
- 这些发现为开发基于的癌症治疗疗法铺平了道路.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K


